Introduction: The Gap Is Closing

For years, the choice was simple: Pay $1,300 for Wegovy® or $300 for compounded. In 2025, that changed.

The 2025 Update: Novo Nordisk (the maker of Wegovy) has aggressively lowered prices for self-pay patients to compete with services like Medvi. You can now get name-brand Wegovy for as low as $349/mo through specific direct channels.

The Verdict:

Quick Comparison: At a Glance

FeatureWegovy® (Brand Name)Medvi (Compounded)
Active IngredientSemaglutideSemaglutide
FDA ApprovalYes (Full Drug Approval)Ingredient Only
Best Cash Price$349/mo (Direct Program)~$299/mo (Renewal Cap)
Doctor FeeExtra ($50–$150/visit)Included ($0)
Supply ChainHistory of ShortagesConsistent Supply
AdministrationPre-filled Auto-InjectorSyringe & Vial

1. What Is Wegovy?

Wegovy® is the FDA-approved brand name for Semaglutide, specifically indicated for chronic weight management. It is manufactured by Novo Nordisk.

Unlike Ozempic (which is for diabetes), Wegovy is approved for anyone with a BMI of 30 or higher (or 27 with a related condition). It comes in a color-coded “single-dos” pen that is incredibly easy to use: you press it against your skin, wait for the click, and you are done. There are no needles to see or handle.

2. What Is Medvi?

Medvi is a telehealth platform that prescribes Compounded Semaglutide.

Because Medvi partners with 503B compounding pharmacies, they can ship generic versions of Semaglutide directly to patients. While the liquid in the vial contains the same active molecule as Wegovy, it is mixed in a pharmacy rather than a factory. This allows Medvi to bypass the supply chain bottlenecks that have plagued Novo Nordisk for years.

3. Medication Comparison: Pen vs. Vial

This is the most significant physical difference between the two options.

Wegovy: The “Idiot-Proof” Pen

Wegovy’s delivery system is its most significant selling point. The pen hides the needle, automatically measures the dose, and prevents you from messing it up.

Medvi: The “Hands-O” Vial

Medvi ships a glass vial and a bag of insulin syringes. You must stick the needle into the vial, draw up the correct unit amount (e.g., 20 units), and inject yourself.

4. Cost Comparison: The “Total Cost Audit.

In 2025, comparing costs is tricky because of NovoNordisk’s new “Cash Pa” offers.

Option A: Wegovy via “Novo Direct

Option B: Medvi All-Inclusive

The Math: Medvi saves you roughly $150–$200 every month compared to the “cheaper way to get brand-name Wegovy, primarily because the doctor is included.

5. Insurance Coverage

Wegovy:

Medvi:

6. Availability & Shortages

Wegovy:

While supply has improved in 2025, the” starter dose” (0.25mg and 0.5mg) is still prone to regional outages. It is frustrating to get a prescription and then call 5 pharmacies only to be told, “We don’t know when we’ll get more.”

Medvi:

Compounding pharmacies create medication on demand. They buy the raw pharmaceutical ingredient in bulk (Semaglutide Base) and mix it as orders come in.

7. Effectiveness & Results

Both medications utilize Semaglutide.

8. Final Verdict: Which Is Better?

Choose Wegovy® If:

Choose Medvi If:

Recommendation: For the average cash-pay patient, Medvi remains the superior financial choice due to its bundled service model.

Check Your Eligibility for Medvi

rosonviyavong
Author: rosonviyavong

Leave a Reply

Your email address will not be published. Required fields are marked *